Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Zink

Showing results (61-70 of 117) with videos related to

Pageof 12
Sort By:
Neuroimage|July 4, 2009
MR spectroscopic evaluation of N-acetylaspartate's T2 relaxation time and concentration corroborates white matter abnormalities in schizophreniaNuran Tunc-Skarka, Wolfgang Weber-Fahr, Mareen Hoerst, et al.
Schizophrenia Bulletin|October 30, 2012
Stable cognitive deficits in schizophrenia patients with comorbid obsessive-compulsive symptoms: a 12-month longitudinal studyFrederike Schirmbeck, Franziska Rausch, Susanne Englisch, et al.
Clinical Neuropharmacology|August 1, 2009
Clozapine-induced obsessive-compulsive syndromes improve in combination with aripiprazoleSusanne Englisch, Christine Esslinger, Dragos Inta, et al.
Schizophrenia Research|April 6, 2004
Differential effects of long-term treatment with clozapine or haloperidol on GABAA receptor binding and GAD67 expressionMathias Zink, Andrea Schmitt, Brigitte May, et al.
Neurobiology of Disease|July 18, 2006
IL-6 knockout mice exhibit resistance to stress-induced development of depression-like behaviorsSabine Chourbaji, Alexandre Urani, Ioana Inta, et al.
Psychiatry Research|September 19, 2013
Altered phospholipid metabolism in schizophrenia: a phosphorus 31 nuclear magnetic resonance spectroscopy studyWolfgang Weber-Fahr, Susanne Englisch, Andrea Esser, et al.
Psychiatric Genetics|April 26, 2012
Polymorphisms in the glutamate transporter gene SLC1A1 and obsessive-compulsive symptoms induced by second-generation antipsychotic agentsFrederike Schirmbeck, Vanessa Nieratschker, Josef Frank, et al.
Psychiatry Research|June 2, 2014
Neurocognitive capabilities modulate the integration of evidence in schizophreniaSarah Eifler, Franziska Rausch, Frederike Schirmbeck, et al.
Neurochemical Research|March 1, 2003
Effects of long-term antipsychotic treatment on NMDA receptor binding and gene expression of subunitsAndrea Schmitt, Mathias Zink, Bettina Müller, et al.
Schizophrenia Research. Cognition|January 31, 2018
Overconfidence in incorrect perceptual judgments in patients with schizophreniaSteffen Moritz, Nora Ramdani, Helena Klass, et al.
Pageof 12

Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
Neuroimage|July 4, 2009
MR spectroscopic evaluation of N-acetylaspartate's T2 relaxation time and concentration corroborates white matter abnormalities in schizophreniaNuran Tunc-Skarka, Wolfgang Weber-Fahr, Mareen Hoerst, et al.
Schizophrenia Bulletin|October 30, 2012
Stable cognitive deficits in schizophrenia patients with comorbid obsessive-compulsive symptoms: a 12-month longitudinal studyFrederike Schirmbeck, Franziska Rausch, Susanne Englisch, et al.
Clinical Neuropharmacology|August 1, 2009
Clozapine-induced obsessive-compulsive syndromes improve in combination with aripiprazoleSusanne Englisch, Christine Esslinger, Dragos Inta, et al.
Schizophrenia Research|April 6, 2004
Differential effects of long-term treatment with clozapine or haloperidol on GABAA receptor binding and GAD67 expressionMathias Zink, Andrea Schmitt, Brigitte May, et al.
Neurobiology of Disease|July 18, 2006
IL-6 knockout mice exhibit resistance to stress-induced development of depression-like behaviorsSabine Chourbaji, Alexandre Urani, Ioana Inta, et al.
Psychiatry Research|September 19, 2013
Altered phospholipid metabolism in schizophrenia: a phosphorus 31 nuclear magnetic resonance spectroscopy studyWolfgang Weber-Fahr, Susanne Englisch, Andrea Esser, et al.
Psychiatric Genetics|April 26, 2012
Polymorphisms in the glutamate transporter gene SLC1A1 and obsessive-compulsive symptoms induced by second-generation antipsychotic agentsFrederike Schirmbeck, Vanessa Nieratschker, Josef Frank, et al.
Psychiatry Research|June 2, 2014
Neurocognitive capabilities modulate the integration of evidence in schizophreniaSarah Eifler, Franziska Rausch, Frederike Schirmbeck, et al.
Neurochemical Research|March 1, 2003
Effects of long-term antipsychotic treatment on NMDA receptor binding and gene expression of subunitsAndrea Schmitt, Mathias Zink, Bettina Müller, et al.
Schizophrenia Research. Cognition|January 31, 2018
Overconfidence in incorrect perceptual judgments in patients with schizophreniaSteffen Moritz, Nora Ramdani, Helena Klass, et al.
Pageof 12